Trial intelligence / Profile preview

Change of Inspiratory Peak Flow After Bronchial Dilatation in COPD

NCT00561886Phase 4Completed

Sponsor
Johannes Gutenberg University Mainz
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Johannes Gutenberg University Mainz. Started Apr 2007; status: completed.

02

Drugs

formoterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00561886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00561886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call